Literature DB >> 31392140

Can the interplay between androgen signaling and PSMA expression be leveraged for theranostic applications?

Jaspreet S Batra1, Kenneth J Pienta2, Martin G Pomper1,2, Michael A Gorin1,2, Steven P Rowe1,2.   

Abstract

Entities:  

Year:  2019        PMID： 31392140      PMCID： PMC6642980          DOI： 10.21037/tau.2019.03.13

Source DB:  PubMed          Journal:  Transl Androl Urol        ISSN： 2223-4683


× No keyword cloud information.
  8 in total

1.  Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen.

Authors:  Michael J Evans; Peter M Smith-Jones; John Wongvipat; Vincent Navarro; Sae Kim; Neil H Bander; Steven M Larson; Charles L Sawyers
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-23       Impact factor: 11.205

2.  Flare on Serial Prostate-Specific Membrane Antigen-Targeted 18F-DCFPyL PET/CT Examinations in Castration-Resistant Prostate Cancer: First Observations.

Authors:  Katherine A Zukotynski; John Valliant; François Bénard; Steven P Rowe; Chun K Kim; Martin G Pomper; Steve Y Cho
Journal:  Clin Nucl Med       Date:  2018-03       Impact factor: 7.794

3.  68Ga-PSMA-11 PET Imaging of Response to Androgen Receptor Inhibition: First Human Experience.

Authors:  Thomas A Hope; Charles Truillet; Eric C Ehman; Ali Afshar-Oromieh; Rahul Aggarwal; Charles J Ryan; Peter R Carroll; Eric J Small; Michael J Evans
Journal:  J Nucl Med       Date:  2016-09-22       Impact factor: 10.057

4.  [177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study.

Authors:  Michael S Hofman; John Violet; Rodney J Hicks; Justin Ferdinandus; Sue Ping Thang; Tim Akhurst; Amir Iravani; Grace Kong; Aravind Ravi Kumar; Declan G Murphy; Peter Eu; Price Jackson; Mark Scalzo; Scott G Williams; Shahneen Sandhu
Journal:  Lancet Oncol       Date:  2018-05-08       Impact factor: 41.316

Review 5.  Theranostics of prostate cancer: from molecular imaging to precision molecular radiotherapy targeting the prostate specific membrane antigen.

Authors:  Harshad R Kulkarni; Aviral Singh; Thomas Langbein; Christiane Schuchardt; Dirk Mueller; Jingjing Zhang; Coline Lehmann; Richard P Baum
Journal:  Br J Radiol       Date:  2018-06-01       Impact factor: 3.039

6.  Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases.

Authors:  D G Bostwick; A Pacelli; M Blute; P Roche; G P Murphy
Journal:  Cancer       Date:  1998-06-01       Impact factor: 6.860

Review 7.  Metastatic prostate cancer remains incurable, why?

Authors:  Liang Dong; Richard C Zieren; Wei Xue; Theo M de Reijke; Kenneth J Pienta
Journal:  Asian J Urol       Date:  2018-11-29

8.  Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer.

Authors:  Katharina Lückerath; Liu Wei; Wolfgang P Fendler; Susan Evans-Axelsson; Andreea D Stuparu; Roger Slavik; Christine E Mona; Jeremie Calais; Matthew Rettig; Robert E Reiter; Ken Herrmann; Caius G Radu; Johannes Czernin; Matthias Eiber
Journal:  EJNMMI Res       Date:  2018-10-29       Impact factor: 3.138
  8 in total
  3 in total

Review 1.  Neoadjuvant hormonal therapy before radical prostatectomy in high-risk prostate cancer.

Authors:  Gaëtan Devos; Wout Devlies; Gert De Meerleer; Marcella Baldewijns; Thomas Gevaert; Lisa Moris; Daimantas Milonas; Hendrik Van Poppel; Charlien Berghen; Wouter Everaerts; Frank Claessens; Steven Joniau
Journal:  Nat Rev Urol       Date:  2021-09-15       Impact factor: 14.432

2.  Prostate-specific membrane antigen modulates the progression of prostate cancer by regulating the synthesis of arginine and proline and the expression of androgen receptors and Fos proto-oncogenes.

Authors:  Xi Hong; Liang Mao; Luwei Xu; Qiang Hu; Ruipeng Jia
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

3.  Impact of Androgen Receptor Activity on Prostate-Specific Membrane Antigen Expression in Prostate Cancer Cells.

Authors:  Ulrich Sommer; Tiziana Siciliano; Celina Ebersbach; Alicia-Marie K Beier; Matthias B Stope; Korinna Jöhrens; Gustavo B Baretton; Angelika Borkowetz; Christian Thomas; Holger H H Erb
Journal:  Int J Mol Sci       Date:  2022-01-18       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.